Navigation Links
CompanDX Ltd. and Clinical Reference Laboratory, Inc. Sign Multi-Year Deal in Support of Collaborative Gene Signature and Companion Diagnostic Development
Date:2/19/2011

LENEXA, Kan., Feb. 19, 2011 /PRNewswire/ -- CompanDX Ltd., bioinformatics partner for the life sciences industry, and Clinical Reference Laboratory, Inc. (CRL), provider of laboratory testing services in molecular diagnostics and clinical trials, today announced they entered into a multi-year agreement to collaborate in the development and support of biomarker panels and companion diagnostic development for pharmaceutical, biotech and academic clients worldwide. Under the terms of the agreement, CompanDX will continue its trailblazing bioinformatics work on its "Distiller" platform, which includes the development of the first "Time to Event" breast cancer signature supported by CRL's CLIA-certified laboratory services.

The agreement today paves the way for CRL and CompanDX to deliver "discovery to validated test" services to their respective clients.  "CRL has a strong, long-standing reputation for providing state-of-the-art CLIA-certified testing services. In forging this relationship it allows us to reach both upstream and downstream to significantly broadening our reach into the growing market of Molecular Diagnostics, Stratified Clinical Trails and Personalized Medicine," said AD Sutton, CEO, CompanDX.

"Clients are looking for our help to support their clinical development programmes either by reducing the complexity of genomic or proteomic data or by proving innovative MDx tests that will allow them to stratify clinical trials.  CRL brings a level of expertise in the design and delivery of MDx tests that ideally compliments our innovative approach."

CRL's Executive Director of Molecular Diagnostics, Dr. Heather Fehling agrees, "CRL and CompanDX created a powerful team to help meet client's challenges in identifying meaningful biomarker panels and developing novel MDx testing for those panels.  CRL is excited to link its years of CLIA-certified laboratory experience with CompanDX's cutting edge bioinformatics tools to create a unique team offering quality molecular services."

CompanDX's bioinformatics technology will be exhibited at CRL's Booth #630 at the Molecular Medicine Tri-Conference in San Francisco from February 23-25, 2011. CompanDX will also present three posters at the main Tri-Conference, describing novel "Time to Event" breast cancer and "Effect Based" TB tests and an innovative systems biology tool "Therapy Distiller."  In addition, Adam Gouldsworthy, Ph.D., Business Development Manager, CompanDX is presenting a talk, ""Distilling" Personalized Medicine – From Biomarker Discovery to "Time-to-Event Prognostics" at the Early Oncology Partnering Forum in San Francisco on February 21 at 3.26 p.m.

About CompanDX Ltd.

CompanDX is a biomarker discovery and service company that uses its "Distiller" platform to derive small composite biomarker panels from clients genomic and proteomic data in support of stratified clinical trials.  Privately-held, CompanDX is based in Nottingham, UK. Investors in the company include Lachesis and Mobius Funds. Additional information is available at www.compandx.com

About Clinical Reference Laboratory, Inc.

Established in 1979, CRL is a privately held reference laboratory in Lenexa, Kansas offering leading-edge testing services in the areas of Clinical Trials, Corporate Wellness Programs, Genomics, Insurance, Molecular Diagnostics, BioAnalytics and Toxicology. CRL is one of the largest single-site laboratories in the US and analyzes over 100 million tests annually.  In addition, CRL has a satellite laboratory near Cambridge, UK.  Additional information is available at www.crlcorp.com.


'/>"/>
SOURCE Clinical Reference Laboratory, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... Feb. 27, 2017 Pulmonary drug delivery market ... from USD 36.10 billion in 2016, at a CAGR ... pulmonary route as an alternate route of drug delivery, ... increasing incidence of respiratory diseases such as COPD, asthma, ... growth during the forecast period. However, emerging markets and ...
(Date:2/28/2017)... , Feb. 27, 2017  Clarivate Analytics marks the passing of ... thanks for his contributions to information science in the service of scientific ... the development of an indexing system that revolutionized the way researchers work ... Continue Reading ... ...
(Date:2/28/2017)... 28, 2017 Research and Markets has ... Forecasts 2014-2025" report to their offering. ... The global digestive ... by 2025. Growing consumer awareness regarding the severity of digestive ... to stimulate industry growth over the forecast period. The increasing ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... Anahata Ananda of Shamangelic ... happy to announce her “Spring Rejuvenation in Sedona” personally tailored retreats. For those ... the winter-weary soul an excellent opportunity to come out of hibernation and do ...
(Date:2/27/2017)... ... ... Elisa Guajardo Carothers is not your typical author. She went from working as a movie ... writes about God, when she isn’t swimming as a performing mermaid. , Her book isn’t ... Satan),” she offers a comedic look at the dysfunctions of God’s family, before Lucifer was ...
(Date:2/27/2017)... (PRWEB) , ... February 26, 2017 , ... Miro is ... pioneer sound and video system brings songs, movies, TV shows and much more apps ... offers clear, high-definition sound. An immersive view of 1280 x 720 provides crisp images ...
(Date:2/27/2017)... BC (PRWEB) , ... February 27, 2017 , ... ... drug rehabilitation and alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ ... to its team. The new hire, Mackenzie Alsager, showcases the Centre's commitment to ...
(Date:2/27/2017)... ... February 27, 2017 , ... New Jersey ranks among the ... types and genders. And the need for advanced services is growing. , Project ... cancer care program, in collaboration with their non-profit partners in their fight against cancer ...
Breaking Medicine News(10 mins):